Company: LNAI
Filing Date: 2025-12-03
Form Type: 424B5
Source: 0001731122-25-001626
Chunk: 0

Company: Lunai Bioworks Inc.
Filing Date: 2025-12-03
Form: 424B5
Chunk 0
---
| Prospectus Supplement                  | Filed pursuant to Rule 424(b)(5)      |
| (To Prospectus dated November 6, 2024) | Registration Statement No. 333-282898 |

<div align='center'>Lunai Bioworks Inc.

Up to $11,702,826 of Common Stock</div>

We
have entered into an ATM Sales Agreement (the “Sales
Agreement”) with Dawson James Securities,
Inc. (“Dawson James”) relating to
shares of our common stock, par value $0.0001 per share, (the “Common Stock”)
offered by this prospectus supplement and
the accompanying prospectus, filed as part of our registration statement
on Form S-3 (File No. 333-282898). In accordance with the terms
of the Sales Agreement, under this prospectus supplement, we may offer
and sell shares of our Common Stock having an aggregate offering price
of up to $11,702,826 from time to time through Dawson James, acting as our sales agent.

Sales of our Common Stock, if
any, under this prospectus supplement and the
accompanying prospectus will be made in sales deemed to
be “at the market offerings” as defined
in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended
(the “Securities Act”), including sales
made directly on or through the Nasdaq Capital Market (“Nasdaq”) or any other
existing trading market in the United States
for our Common Stock, sales made to or through
a market maker other than on an exchange or otherwise,
directly to Dawson James as principal,
in privately negotiated transactions, in
block trades and/or in any other method permitted
by law. Dawson James is not required to sell any specific amount of Common Stock but will
use its commercially reasonable efforts
consistent with its
normal trading and sales practices and applicable
laws and regulations, subject to the terms of the Sales
Agreement, on mutually agreed terms between
Dawson James and us. There is no arrangement for
funds to be received in any escrow,
trust or similar arrangement. See the section
entitled “Plan of Distribution” for additional information.

The compensation to Dawson James for sales
of Common Stock sold pursuant
to the Sales Agreement will be 3.0% of the gross
proceeds of any shares of Common Stock sold under
the Sales Agreement